| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.42 | 3e-14 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.41 | 9e-14 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-11 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-10 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |